Journal article
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE
Abstract
BACKGROUND: In the phase 2 PACIFIC-STROKE trial (Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following Acute Noncardioembolic Stroke), asundexian, an oral factor XIa inhibitor, did not increase the risk of hemorrhagic transformation (HT). In this secondary analysis, we aimed to investigate the frequency, types, and risk factors of HT on brain magnetic resonance imaging (MRI).
METHODS: This was a secondary …
Authors
Chen C-H; Shoamanesh A; Colorado P; Saad F; Lemmens R; De Marchis GM; Caso V; Xu L; Heenan L; Masjuan J
Journal
Stroke, Vol. 55, No. 6, pp. 1477–1488
Publisher
Wolters Kluwer
Publication Date
June 2024
DOI
10.1161/strokeaha.123.045204
ISSN
0039-2499